Objective: We investigated whether diffusion tensor imaging (DTI) could reveal early hippocampal damage and clinically relevant correlates of memory impairment in persons with clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS). Methods: A total of 37 persons with CIS, 32 with MS and 36 controls prospectively included from 2011 to 2014 were tested for cognitive performances and scanned with 3T-magnetic resonance imaging (MRI) to assess volumetric and DTI changes within the hippocampus, whole brain volume and T2-lesion load. Results: While there was no hippocampal atrophy in the CIS group, hippocampal fractional anisotropy (FA) was significantly decreased compared to controls. Decrease in hippocampal FA together with increased mean diffusivity (MD) was even more prominent in MS patients. In CIS, hippocampal MD was correlated with episodic verbal memory performance (r = −0.57, p = 0.0002 and odds ratio (OR) = 0.058, 95% confidence interval (CI) = 0.0057-0.59, p = 0.016 adjusted for age, gender, depression and T2-lesion load), but not with cognitive tasks unrelated to hippocampal functions. Hippocampal MD was the only variable discriminating memory-impaired from memory-preserved persons with CIS (area under the curve (AUC) = 0.77, sensitivity = 90.0%, specificity = 70.3%, positive predictive value (PPV) = 52.9%, negative predictive value (NPV) = 95.0%). Conclusion: DTI alterations within the hippocampus might reflect early neurodegenerative processes that are correlated with episodic memory performance, discriminating persons with CIS according to their memory status.
Introduction
Cognitive impairment is frequent in multiple sclerosis (MS) 1, 2 and strongly impacts quality of life and vocational status. 3 The two most frequently affected domains are information processing speed (IPS) and episodic memory. 1 While IPS impairment is usually explained by disconnections due to demyelinating lesions and diffuse brain damage, 4 several groups have reported that memory impairment could be more specifically related to hippocampal atrophy. [5] [6] [7] [8] Significant memory impairment is already present at the stage of clinically isolated syndrome (CIS), 9, 10 the first clinical episode suggestive of MS. However, hippocampal damage is typically not detected at this early stage of MS because atrophy is not yet observed or still confined to few locations such as the thalamus or the striatum. [11] [12] [13] [14] To the best of our knowledge, only one study has reported hippocampal atrophy in a CIS group with high T2-lesion load. 15 Therefore, there is a need for imaging biomarkers more sensitive than atrophy, especially at the stage of CIS, which could reflect clinically relevant hippocampal alterations to help the development and validation of future neuroprotective strategies.
Diffusion tensor imaging (DTI) has been efficiently used to reveal widespread white-matter damages from the stage of CIS 16 but less consistently within grey matter. 17, 18 Specifically, there is no report of altered DTI within the hippocampus of persons with CIS (PwCIS) and no strong imaging correlate of memory impairment at this stage. Outside the field of MS, DTI has revealed subtle and early hippocampal alterations in Alzheimer's disease, 19 but it is currently unknown whether this technique can also be sensitive enough to capture clinically relevant modifications at the very early stage of MS.
In this study, we hypothesized that microstructural damage contributing to early memory impairment could occur in the hippocampus at the stage of CIS and that it might be measurable with DTI while there is no hippocampal atrophy. To test this hypothesis, we measured hippocampal volume and DTI metrics within the hippocampus of PwCIS to look for correlations with episodic memory scores and to test their ability to discriminate between memory-impaired and memory-preserved PwCIS. A group of healthy subjects and a group of persons with MS (PwMS) were used as negative and positive controls, respectively.
Methods

Participants
All subjects were prospectively enrolled from 2011 to 2014 at our MS centre. Written informed consent was obtained prior to participation.
The main population of interest consisted of 37 PwCIS enrolled prospectively after approval by the local institutional ethics review board (NCT01865357) between 2 and 6 months after a first clinical event compatible with a demyelinating inflammatory syndrome. At least two clinically silent lesions with 3 mm minimum diameter were needed for inclusion. One had to be cerebral (ovoid or periventricular), while the other could be located in spine or brain. Exclusion criteria were as follows: contraindications to magnetic resonance imaging (MRI), presence of other neurologic, psychiatric or systemic diseases, steroid treatment within 1 month, starting or stopping antidepressants or anxiolytic treatments within 2 months of MRI and neuropsychological examination.
We pooled these data with data from a MS study (NCT01207856) to analyse patients with long-lasting  disease as a positive control. A total of 32 PwMS  diagnosed according to the 2005-revised McDonald  criteria 20 were included (27 relapsing-remitting, 3 secondary progressive and 2 primary progressive form of MS). Exclusion criteria were dementia (Mini Mental State Examination < 27), other neurologic or psychiatric disorders, drug or alcohol abuse, relapse and/or steroid treatment within 2 months, or severe depression (Beck Depression Inventory (BDI) > 27).
A total of 76 healthy control (HC) subjects, included as negative controls, were free of neurologic, psychiatric, or systemic diseases, and drug or alcohol abuse. In all, 54 subjects were tightly matched for age, sex and educational level to PwCIS to calculate cognitive z-score (see below). The 22 additional subjects were matched for age, sex and educational level to PwMS.
Neuropsychological testing
All patients and controls performed the Symbol Digit Modalities Test (SDMT) to assess IPS and the forward digit span subtest of the Wechsler Adult Intelligence Scale III (WAIS-III) to assess attention/working memory. In order to assess hippocampal functions (verbal learning and recall), PwCIS and matched controls performed the selective reminding test (SRT), while PwMS and matched controls performed the California Verbal Learning Test (CVLT). Indeed, the SRT was frequently used in previous studies of CIS 9, 10 and is part of the brief repeatable battery of neuropsychological testing, 21 while the CVLT was the most common validated task used to assess episodic verbal memory in previous MS studies. 6, 8 The SRT-long-term storage (LTS) and the CVLT-immediate recall were considered as measures of learning performance, and delayed recall (DR)-SRT and DR-CVLT as measures of longterm recall performance. Each subject also completed a standard questionnaire concerning depressive symptoms (BDI). Lower z-score indicates lower performance. A patient was considered impaired in a given cognitive domain if his or her z-score was <−1.5, according to agreedupon threshold. 22 
MRI acquisition
All PwCIs, PwMS and a representative subset of 36 HC were scanned on a 3T Philips Achieva MRI system with an eight-channel SENSE head coil. The protocol included a three-dimensional (3D) gradientecho T1-weighted sequence (TR/TE/TI/flip angle = 8.2/3.5/982 ms/7°, resolution 1 × 1 × 1 mm 3 , 256 mm FOV) and a two-dimensional (2D) axial fluid attenuated inversion recovery (FLAIR) sequence (TR/TE/ TI = 11,000/140/2800 ms, resolution 1 × 1.1 × 3 mm 3 , 230 mm FOV). A diffusion tensor echo-planar-imaging (EPI) pulse sequence was also acquired: TR/ TE = 11,676/60, 1.6 × 1.6 × 1.6 mm resolution, 230 mm FOV, with b = 1000 s/mm 2 (Δ = 29.4 ms, δ = 12.9 ms) in 20 non-co-linear directions and four sets of b = 0 s/mm 2 .
MRI analyses
Lesion load was determined using co-registered T1 and FLAIR sequences and a semi-automated segmentation pipeline based on local thresholding 23 followed by manual correction by a blinded expert (V.P., a neurologist with 4 years of experience).
For volumetric analyses of brain structures, T1-weighted images were processed using the volBrain system (http://volbrain.upv.es). After denoising, 24 images were affine-registered 25 into the Montreal Neurological Institute (MNI) space and the total brain volume was estimated. Hippocampus was automatically segmented with a patch-based multitemplates method described in detail elsewhere 26 that uses expert manual segmentations in MNI space as priors. Anatomical boundaries of the hippocampus were defined according to the European Alzheimer's Disease Consortium and Alzheimer's Disease Neuroimaging Initiative (EADC-ADNI) Harmonized Protocol. 27 Every mask was then blindly checked and manually corrected (V.P.) for inappropriate inclusion of para-hippocampal T1-hypointense lesions, choroidal plexus and/or cerebrospinal fluid (CSF) 'pockets'. To control for variations in head size, total brain volumes and hippocampal volumes were scaled using the volumetric scaling factor determined through the affine registration to the MNI brain template.
An in-house pipeline (dtiBrain) was used to process diffusion-weighted images (DWI). First, images were denoised 28 in order to improve signal-to-noise ratio. Then, head displacement and distortions induced by eddy currents were corrected by performing affine registration 25 of all DWI to the b0 images. The direction table was updated with the estimated motion matrices. To compensate for EPI distortion, a nonrigid registration of DWI to the subject's T1-weighted images in MNI space was performed using advanced neuroimaging tools (ANTs). 25 For that purpose, we found that registration of mean diffusivity (MD) map, derived from DWI, to CSF probability map, derived from T1, provided the most accurate strategy by visual inspection of the hippocampal areas. Then, a diffusion tensor model was fitted at each voxel using FSL 5.0 (http://fsl.fmrib.ox.ac.uk/fsl) to measure mean fractional anisotropy (FA) and MD within the hippocampal masks previously generated from T1-weighted images (Figure 1 (a)-(c)).
Statistical analyses
Right and left hippocampal values were averaged. Statistical analyses were performed with Stata software 12 (StataCorp) and Prism software 6 (Graphpad). The distribution of all continuous data was tested with the Shapiro-Wilk test. We first compared clinical and imaging characteristics between the three groups (HC, CIS and MS) using the chi-square test for categorical variables, and analysis of variance (ANOVA) or Kruskal-Wallis test (when assumptions of ANOVA were not met) for ordinal variables followed by appropriate post hoc tests (Tukey-Kramer or Dunn test, respectively), and adjustment on age and gender. If only two groups had to be compared, Student's t-test or Mann-Whitney test was used as appropriate. Cohen's d was used to measure the effect size. Then, relationships between clinical scores and quantitative imaging variables were assessed using correlation coefficients (Pearson or Spearman according to statistical distribution) for CIS and MS groups, respectively. The associations were further tested in multivariate context to take into account adjustment on covariables fixed according to univariate results and clinical relevance: age, gender, depression and T2-lesion load. For that purpose, cognitive performances (dependent variables) were predicted with regression models. Linear regression model was used whenever possible, while logistic regression was seen as the appropriate alternative for categorical outcome variables by dichotomizing the performances; a log transformation was applied when needed to achieve normality. Considering the issue of multiple comparisons, Sidak's correction was used to reduce the risk of type I error. Finally, receiver operating characteristic (ROC) analysis was performed to test the value of DTI to discriminate between memory-impaired PwCIS (z-score DR-SRT <−1.5) versus those with normal memory performance. All tests were twotailed, with a type I error set at α = 0.05. 
Results
Clinical characteristics and general MRI features
A total of 37 PwCIS, 32 PwMS and 36 HC assessed with MRI were included (Table 1) . Groups were comparable for age, sex ratio and educational level. PwCIS and PwMS showed significantly higher depression scores than controls but they were not significantly different from each other (p = ns; d = 0.39). As expected, Expanded Disability Status Scale (EDSS) and T2-lesion load were significantly lower in PwCIS than in PwMS. PwCIS presented no global brain atrophy compared to HC whereas PwMS did.
Cognitive assessment
Median z-scores and percentages of impaired PwCIS and PwMS (z-score < −1.5) are reported in Table 2 . Regarding mean or median z-scores, as expected, PwMS performed significantly worse than PwCIS for all the tests. Verbal episodic memory performance was the most frequently affected domain in PwCIS (27.0%) whereas slowing of IPS was the most frequently affected domain in PwMS (78.1%).
Hippocampal volume and DTI measures
Hippocampal volumes normalized for head size were not significantly different between groups (p = 0.19). PwMS showed slightly lower volumes compared to HC even though this difference did not reach significance (mean volume = 9.72 mL and 9.99 mL, respectively, d = 0.31; Figure 1(d) ). Interestingly, PwCIS and HC were thoroughly similar for their hippocampal volumes (mean volume = 10.06 mL and 9.99 mL, respectively, d = 0.09; Figure 1(d) ).
Hippocampal FA and MD were significantly different between groups (p < 0.0001 for both measures, adjusted for age and gender: FA = 0.171, 0.162 and 0.149; MD = 1.269, 1.281 and 1.319 ×10 −3 mm 2 /s for HC, CIS and MS groups respectively; Figure 1 (e) and (f)). Post hoc analyses showed that FA was significantly decreased in PwCIS compared to HC (p = 0.050, adjusted for age and gender; d = 0.53), as well as in PwMS compared to HC (p < 0.0001; d = 1.05) and compared to PwCIS (p = 0.007; d = 0.70). In PwMS, MD was significantly increased compared to HC (p < 0.0001; d = 1.21) and compared to PwCIS (p = 0.004; d = 0.65). The difference in MD between PwCIS and HC did not reach a statistically significant level (p = 0.093; d = 0.41), but the graphical distribution of hippocampal MD values in the CIS group showed a sub-group with distinctly higher MD values compared to HC.
Correlations between MRI measures and cognitive performance
In the CIS group, in univariate analyses, the hippocampal MD was the only metric strongly correlated with long-term recall (r = −0.57, p = 0.0002); a correlation that remains significant even after correction for the 32 multiple comparisons run between MRI and clinical data (p = 0,005) ( Table 3) . By contrast, hippocampal volume and T2-lesion load were not correlated with episodic memory. In multivariate analysis, after adjusting for age, gender, depression and T2-lesion load, the correlation between hippocampal MD and performances on long-term recall remained significant with an odds ratio of 0.058 (95% confidence interval (CI) = 0.0057-0.59, p = 0.016).
In the MS group, the performances on learning trials were correlated with hippocampal volumes (r = 0.44, p = 0.01 and β = 1.23, 95% CI = 0.12-2.34, p = 0.032 after adjustments). IPS measures were correlated with T2-lesion load (r = −0.51, p = 0.004 and β = −3.5 × 10 −5 , 95% CI = −6.8 × 10 −5 to -3.12 × 10 −6 , p = 0.033 after adjustments) but also with both hippocampal FA and MD (respectively, r = 0.36, p = 0.04, non-significant after adjustments and r = −0.52, p = 0.002; β = −8.95, 95% CI = −15.77 to -2.13, p = 0.012 after adjustments).
Hippocampal MD discriminates between memory-impaired and memory-preserved PwCIS
Regarding the strong association between hippocampal MD and long-term recall memory performances, we tested whether this parameter could discriminate memory-impaired PwCIS from those 
T2-Lesion load Hippocampal volume
Hippocampal FA Hippocampal MD CIS (n = 37) Information processing speed r = −0.13, p = 0.45 r = 0.04, p = 0.84 r = 0.10 p = 0.54 r = −0.23, p = 0.18
Attention/working memory r = −0.16, p = 0.36 r = −0.11, p = 0.53 r = −0.17, p = 0.31 r = −0.01, p = 0.98 Episodic verbal memory (learning trials) r = −0.24, p = 0.14 r = 0.02, p = 0.93 r = −0.07, p = 0.67 r = −0.29, p = 0.08
Episodic verbal memory (long-term recall) r = −0.07, p = 0.68 r = 0.02, p = 0.89 r = 0.01, p = 0.96 r = −0.57, p = 0.0002 (p = 0.016) a MS (n = 32) Information processing speed r = −0.51, p = 0.004 (p = 0.033) b r = 0.25, p = 0.18 r = 0.36, p = 0.04 (n.s.) a r = −0.52, p = 0.002 (p = 0.012) a Attention/working memory r = −0.16, p = 0.38 r = 0.17, p = 0.35 r = 0.16, p = 0.40 r = −0.05, p = 0.76 Episodic verbal memory (learning trials) r = −0.15, p = 0.41 r = 0.44, p = 0.01 (p = 0.032) a r = 0.19, p = 0.31 r = −0.30, p = 0.09
Episodic verbal memory (long-term recall) r = −0.10, p = 0.60 r = 0.29, p = 0.10 r = 0.12, p = 0.52 r = −0.12, p = 0.52 CIS: clinically isolated syndrome; FA: fractional anisotropy; MD: mean diffusivity; MS: multiple sclerosis. To explore multiple leads, p-values of univariate correlations were uncorrected for multiple comparisons in this table. a Adjusted on age, gender, depression and T2-lesion load. b Adjusted on age, gender and depression.
with normal long-term recall. PwCIS were dichotomized in two subgroups according to their long-term memory performances (i.e. DR-SRT z-score < −1.5). Using ROC analysis we showed that a threshold MD value (MD = 1.278 × 10 −3 mm 2 /s) was discriminating these two subgroups with 90.0% sensitivity, 70.3% specificity, 52.9% positive predictive value (PPV) and 95.0% negative predictive value (NPV) (area under the curve = 0.77, 95% CI = 0.62-0.92, p = 0.013; Figure 2(a) ). Hippocampal MD was the only demographical, clinical or radiological characteristic significantly different between memory-impaired and memory-preserved PwCIS (p = 0.011; Figure 2 (b) and Table 4 ).
Discussion
In this study, hippocampal microstructural alterations measured by DTI appear to be already present in the early stages of MS (PwCIS), while no significant hippocampal or global brain atrophy compared to HC is evident. Furthermore, increased hippocampal MD was associated with early memory impairment in these PwCIS.
A quarter of our population of PwCIS showed episodic verbal memory impairment in learning and retrieval tasks which is consistent with previous studies using the same test. 9,10 Interestingly, memory impairment was more frequent than slowing of IPS in PwCIS. This observation suggests that a neurodegenerative process starts early within the hippocampus contributing to memory decline, even at a stage where IPS is relatively preserved because complete disconnection phenomena due to widespread demyelination are generally lower at the CIS stage than later on. 4 Furthermore, our PwCIS were not treated with disease-modifying therapies, avoiding bias linked to heterogeneous therapeutic response.
Our data support the concept that early memory deficit in MS could be related to specific hippocampal vulnerability, independent of the extent of focal white-matter lesions. Hippocampal FA was significantly decreased in the CIS group and even more in the MS group, in which a significant increase in hippocampal MD was also observed. In previous work assessing PwCIS, deep grey-matter DTI changes were detected, while no hippocampal DTI changes were apparent. 17 However, the sensitivity to DTI changes in the hippocampus might have been hampered by partial voluming effects due to a larger voxel size (3.33mm × 3.33mm × 3.00mm), 17 compared to our 1.6 mm 3 voxel size. We also believe that applying a denoising procedure further increased our sensitivity towards microstructural alterations detected by DTI, enabling our findings. 28 In support of the clinical relevance of our finding of early hippocampal damage in PwCIS, we were able to show a strong and independent correlation of hippocampal MD with a hippocampus-dependent task (DR-SRT), but not with cognitive tasks that are not reliant on hippocampal function (i.e. IPS and attention/working memory, even though some authors argue for a continuum between working memory and long-term memory encoding 29 ). Hippocampal MD in PwCIS was correlated to hippocampal-dependent long-term recall in the absence of significant hippocampal volume loss, suggesting that hippocampal MD reflects an earlier pathophysiological process that likely precedes atrophy. Interestingly, and despite smaller differences between groups, the increase in MD appears to be more clinically relevant than the decrease in FA in the explored context. MD might be more stable and reproducible than FA in the hippocampus (i.e. smaller dispersion of the values, even in the control group), which can be reasonably expected in such a grey-matter structure where diffusion tends to be more isotropic and therefore imperfectly represented by FA as a measure of fibre orientation. Therefore, either FA or MD measure different underlying histological substrate or, more likely, FA is less reliable than MD in grey matter which is in line with previous results. 16, 17 Higher MD might correspond to a mixture of hippocampal demyelination, neuronal or synaptic loss together with inflammatory cells as described in post-mortem studies of MS brains. 30 We also showed that hippocampal MD discriminates memory-impaired from memory-preserved patients with a sensitivity of 90%, a specificity of 70.3% and a NPV of 95.0%. Among clinical and other MRI criteria, hippocampal MD was the only predictor of memory impairment in this group. Therefore, stabilization of low hippocampal MD might be an interesting candidate endpoint (surrogate marker with a very good NPV) in future proof-of-concept phase II clinical trials in CIS and early MS. Unambiguous monitoring of cognitive performances in the context of a neuroprotective agent in clinical trials is complicated by the length of the cognitive testing, the test/retest effect and confounding factors such as participation of the subject, fatigue or depression. 31 In this context, stabilization of low hippocampal MD might provide a complementary and unbiased endpoint. DTI of the hippocampus might also help to improve patient selection by stratifying those with and without hippocampal damage, therefore powering future neuroprotective trials by including more homogeneous population in comparison groups.
In contrast, in PwMS, episodic memory correlated with hippocampal volume, but the correlation between hippocampal MD and memory scores was not significant. This finding suggests that at a more advanced stage, assessing the microstructure of the hippocampus with DTI might no longer be sensitive and relevant. Furthermore, T2-lesion load and hippocampal DTI metrics were correlated with IPS scores. These findings can suggest that hippocampus is involved in IPS but also that hippocampal DTI at the stage of clinically definite MS reflects more general brain damage and in turn correlate better with IPS that has been associated to global cerebral damage. 2 This is consistent with data in the literature showing that cognitive impairment is associated with several imaging metrics in more advanced MS 32 because cognitive impairment is probably the result of a complex interplay between several alterations at this stage. 33 We acknowledge an important shortcoming of this meta-analysis of our data, namely, that the cognitive testing was different for the CIS and MS groups, limiting our ability to directly compare PwCIS to PwMS. Nevertheless, a previous paper reported no difference in sensitivity between SRT and CVLT 34 and furthermore, we believe that the insights gained by separately comparing these groups of patients to matched HC explored with the same tests maintain full validity. We also acknowledge that the sample size of each group is relatively small, and therefore, these results can be viewed as preliminary and need confirmation in a larger cohort of PwCIS. Another limitation is that we did not acquire 3D-double inversion recovery MRI, limiting our ability to detect focal hippocampal lesions. 35 Therefore, our DTI findings might reflect focal, as well as more diffuse alterations in the hippocampus. Because the PPV was only 52.9%, it will be of great interest for future studies to assess whether PwCIS with increased hippocampal MD but preserved memory functions display compensatory mechanisms measured by hippocampal activation and functional connectivity, as demonstrated in PwMS. 36 Similarly, longitudinal data should identify whether those patients are likely to show memory alterations in long-term follow-up. DTI could also be combined with susceptibility weighted imaging that could also reveal subtle alterations because it has been demonstrated that iron deposition is present within the hippocampus at the stage of CIS. 37
In conclusion, episodic memory impairment was correlated with hippocampal DTI changes at the stage of CIS, in the absence of a significant effect of global lesion volume or atrophy on any of the cognitive measures. This argues for a clinically relevant neurodegenerative process occurring in the hippocampus in the early stages of MS and suggests that DTI measurement in this structure might provide a sensitive indicator of early neurodegenerative changes. 
